In particular, individuals who simultaneously carried a glutamic acid polymorphism in β2-AR gene (Gln27Glu) together with the Trp64Arg β3-AR polymorphism had the most markedly reduced risk of breast cancer, with an odds ratio of 0.37 [76]. This evidence concerns the gene ADRB3 and breast carcinoma.